PURPOSE Whether repeated brief seizures can cause neuronal damage is controversial. Cerebrospinal fluid (CSF) total tau (T-tau) and phosphorylated tau (P-tau) measurements have been suggested for the diagnosis of Alzheimer's disease, and T-tau may also be a marker of axonal damage and neuronal degeneration. We studied T-tau and P-tau levels and P-tau/T-tau ratio in CSF after epileptic seizures ...

Neurodegenerative tauopathies characterized by hyperphosphorylated tau include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease (AD). Reducing tau levels improves cognitive function in mouse models of AD and FTDP-17, but the mechanisms regulating the turnover of pathogenic tau are unknown. We found that tau is acetylated and that tau acetylation...

The CSF biomarkers beta-amyloid peptide (Abeta(1-42)), total tau protein (T-tau) and tau phosphorylated at threonine 181 (P-tau(181P)) were determined in autopsy-confirmed Alzheimer's disease patients in order to study possible associations with the epsilon4 allele of APOE and density and spread of plaques (SP) and tangles (NFT). CSF levels of Abeta(1-42), T-tau and P-tau(181P) were determined ...

The major protein subunit of the paired helical filaments (PHF) of Alzheimer disease (AD) is the microtubule-associated protein tau. Tau is a family of phosphopolypeptides that are abnormally phosphorylated in PHF. In this study, a non-PHF pool of tau abnormally phosphorylated at Ser-199/202, and tau not phosphorylated at this site (AD P-tau and AD tau, respectively) were isolated from the 27,0...

‎Let $tau$ be a subgroup functor and $H$ a $p$-subgroup of a finite group $G$‎. ‎Let $bar{G}=G/H_{G}$ and $bar{H}=H/H_{G}$‎. ‎We say that $H$ is $Phi$-$tau$-quasinormal in $G$ if for some $S$-quasinormal subgroup $bar{T}$ of $bar{G}$ and some $tau$-subgroup $bar{S}$ of $bar{G}$ contained in $bar{H}$‎, ‎$bar{H}bar{T}$ is $S$-quasinormal in $bar{G}$ and $bar{H}capbar{T}leq bar{S}Phi(bar{H})$‎. ‎I...

An ever increasing number of patients with neurodegenerative disorders calls for the evaluation of potential diagnostic markers that allow an early diagnosis and an early initiation of specific therapy. Clinical diagnosis of Alzheimer's disease (AD), the most common neurodegenerative disorder, reaches 80-90% accuracy upon autopsy in specialized clinical centers. Diagnosis of AD in early clinica...

Cerebrospinal fluid (CSF) measures of Ab and tau, Pittsburgh Compound B (PIB) imaging and hippocampal atrophy are promising Alzheimer's disease biomarkers yet the associations between them are not known. We applied a validated, automated hippocampal labeling method and 3D radial distance mapping to the 1.5T structural magnetic resonance imaging (MRI) data of 388 ADNI subjects with baseline CSF ...

in this paper the periodic solutions of fourth order delay differential equation of the form $ddddot{x}(t)+adddot{x}(t)+f(ddot{x}(t-tau(t)))+g(dot{x}(t-tau(t)))+h({x}(t-tau(t)))=p(t)$  is investigated. some new positive periodic criteria are given.